XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating Activities    
Net loss $ (11,165) $ (20,209)
Adjustments to reconcile net loss to cash flows from operating activities:    
Depreciation and amortization 310 362
Stock-based compensation expense 478 670
Change in fair value of warrant liability (4,615) (758)
Loss on disposal of intangible asset 99 0
Financing expense 5,607 3,483
Net realized and unrealized gains on marketable securities 0 (65)
Changes in operating assets and liabilities:    
Accounts receivable 224 (545)
Inventory 279 697
Other current assets (160) (65)
Other assets and liabilities (22) (7)
Accounts payable and accrued expenses (626) (1,500)
Net cash used in operating activities (9,591) (17,937)
Investing Activities:    
Addition of intangible asset 0 (99)
Proceeds from sales of marketable securities 0 578
Purchase of property and equipment (60) (149)
Net cash (used in) provided by investing activities (60) 330
Financing Activities:    
Proceeds from April 2024 common stock offering, net 2,403 2,109
Proceeds from exercise of Series J Convertible Preferred Warrants 501 1,482
Proceeds from exercise of April 2024 Warrants, net 2,246 0
Proceeds from issuance of July and August 2024 Common Stock and Warrants, net 2,160 0
Proceeds from warrant inducement in November 2024, net 3,364 0
Proceeds from the exercise of warrants, net 288 120
Payments on finance lease liability 0 (28)
Net cash provided by financing activities 10,962 3,683
Effect of exchange rate changes on cash (16) (13)
Net increase/(decrease) in cash and cash equivalents 1,295 (13,937)
Cash and cash equivalents - beginning of year 3,800 17,737
Cash and cash equivalents - end of year 5,095 3,800
Supplemental schedule of non-cash activities    
Inventory transferred to property, plant and equipment 0 41
Issuance of Common Stock for exercise of Series I Warrants 0 7,623
Issuance of Series J Preferred Stock for exercise of warrants 1,857 2,927
Reclassification of April 2024 warrants to equity 4,217 0
Deemed dividend on Series J Preferred Stock 541 (2,297)
Issuance of Common Stock for conversion of Series J Preferred Stock 1,535 0
Series J Preferred Stock issued for payment in kind dividend 0 121
Supplemental cash flow information    
Cash paid for income taxes $ 7 $ 12